Curzon established to manage cleantech portfolio and raise new funds

Investor

A new UK cleantech investor, Curzon Park Capital, has been spun out of fund manager E-Synergy to handle their £20 million Sustainable Technology Fund and to raise new funds for cleantech investing.  

The STF was set up by E-Synergy in January 2007 to support UK-based entrepreneurs aiming to develop sustainable technology products and services.  Now Curzon Park Capital has been created to focus on supporting the current STF portfolio and to seek out strategic investment opportunities for these companies. The new company is chaired by Edmund Truell, with directors Sam Richardson and Cédriane de Boucaud joining from E-Synergy.

“The Curzon Park Capital team has considerable experience in investing and helping develop cleantech businesses,” said Truell. “We look forward to using our combined expertise, experience and networks to transform those STF businesses which are developing solutions to not only tackle environmental issues and also to provide cost effective and scalable answers to reducing inefficiencies in the resource supply chain.  We are also fostering businesses that are using novel approaches to enhance pharmaceutical research and drug delivery.”

The STF also announced its first investment under Curzon Park Capital’s management, contributing alongside Robeco Private Equity as part of a £2.8 million funding for AWS Eco Plastics. AWS has recently built and now operates Europe’s largest plastic bottle recycling facility.  The capital will finance a move into the production of food grade plastic from recycled materials.

Other companies in the STF portfolio include: Morgan Everett, whose PyroPure system destroys waste at the point of creation, eliminating transport of refuse to landfill; Lysanda, a vehicle emissions monitoring and fuel saving software platform; Q Chip, which is developing nanotechnology for the delivery and slow release of pharmaceuticals; and Aquapharm, a bioprospecting company building a marine microbe library and screening technology for the discovery of drugs, cosmetics and food ingredients.